Clinical Scorecard: Comparison of Minimally Invasive and Open Hepatectomy Outcomes in Obese Patients with Liver Tumors: A Systematic Review and Meta-Analysis
At a Glance
Category
Detail
Condition
Liver tumors in patients with obesity
Key Mechanisms
Minimally invasive hepatectomy (MIH) offers magnified visualization and precise tissue dissection, potentially reducing operative trauma compared to open hepatectomy (OH). Obesity increases surgical complexity due to adipose tissue accumulation and associated inflammation.
Target Population
Patients with obesity undergoing liver tumor resection
Care Setting
Surgical care settings performing liver resections
Key Highlights
MIH is associated with shorter operative time and reduced blood loss compared to OH in obese patients.
MIH results in lower rates of overall and major postoperative complications, including biliary leakage and liver failure.
No significant difference in mortality was observed between MIH and OH groups.
Guideline-Based Recommendations
Diagnosis
Assess liver tumors in patients with obesity considering BMI and associated surgical risks.
Management
Consider minimally invasive hepatectomy (laparoscopic or robotic) as a safe and effective treatment option for obese patients with liver tumors.
Monitor intraoperative parameters closely due to increased difficulty and potential complications related to obesity and pneumoperitoneum.
Monitoring & Follow-up
Monitor for postoperative complications including biliary leakage, liver failure, and overall morbidity.
Assess length of hospital stay and recovery progress post hepatectomy.
Risks
Increased surgical difficulty and risk of conversion in obese patients due to limited surgical field exposure.
Potential intraoperative complications related to CO2 pneumoperitoneum such as venous stasis, respiratory compliance reduction, and cardiac function impairment.
Patient & Prescribing Data
Obese patients undergoing liver tumor resection
MIH demonstrates benefits including reduced operative time, blood loss, transfusion rates, and postoperative complications without increasing mortality risk.
Clinical Best Practices
Utilize minimally invasive techniques (laparoscopic or robotic) for hepatectomy in obese patients when feasible.
Prepare for potential challenges related to obesity such as limited exposure and pneumoperitoneum effects.
Implement thorough preoperative assessment and postoperative monitoring to mitigate risks.
Consider tumor size and patient-specific factors when selecting surgical approach.
Kidney cancer is a growing global health problem, and both clinicians and policymakers need to prepare for a steep rise in the number of cases,” said Alexander Kutikov, MD, FACS, Chair of the Department of Urology at Fox Chase Cancer Center, and senior author of a landmark international study published in European Urology, which demonstrates that if current trends continue, kidney cancer cases could double by 2050
